Visit OPKO.com
 
  Rayaldee is now approved! Visit the new Rayaldee Web Site  
   
     
 

Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism

  

Recent News:

OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
September 15, 2020

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
June 01, 2020

OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies
March 25, 2020
 
     
 

 

  

© 2020 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use